Company news
Insulet Corporation news in 2022
Insulet Corporation's news releases, calls and decks from 2022, newest first.
Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 Controller
November 13, 2022
Insulet Issued Voluntary Medical Device Correction for Omnipod DASH® Personal Diabetes Manager on October 17, 2022
November 3, 2022
Insulet Reports Third Quarter 2022 Revenue Increase of 24% Year-Over-Year (29% Constant Currency¹)
November 2, 2022
Insulet Recognizes World Diabetes Day and Diabetes Awareness Month Throughout November
October 31, 2022
Insulet to Announce Third Quarter 2022 Financial Results on November 3, 2022
September 21, 2022
Insulet Announces CE Mark Approval for Omnipod® 5 Automated Insulin Delivery System
September 19, 2022
Insulet Announces FDA Clearance of Omnipod® 5 for Children Aged Two Years and Older with Type 1 Diabetes
August 21, 2022
Insulet Reports Second Quarter 2022 Revenue Increase of 14% Year-Over-Year (18% Constant Currency¹)
August 3, 2022
Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System
July 31, 2022
Insulet to Announce Second Quarter 2022 Financial Results on August 4, 2022
June 29, 2022
Omnipod® 5 Automated Insulin Delivery System Significantly Improves Glycemic Outcomes Over 12 Months of Use in Children Aged 2 through 5.9 Years
June 2, 2022
Insulet to Present at the William Blair & Company 42nd Annual Growth Stock Conference
June 1, 2022
Insulet Hosts Groundbreaking Ceremony for its New Manufacturing Facility in Malaysia
May 31, 2022
Insulet Reports First Quarter 2022 Revenue Increase of 17% Year-Over-Year
May 4, 2022
Insulet Announces CEO Transition
May 4, 2022
Insulet’s 2021 Sustainability Report Reveals Progress on Strategy to Deliver Growth with Purpose
May 1, 2022
Insulet Presents New Omnipod® 5 System Data for Type 1 and Type 2 Diabetes
April 26, 2022
Insulet to Announce First Quarter 2022 Financial Results on May 5, 2022
April 6, 2022
Insulet Reports Full Year 2021 Revenue Increase of 21% and Fourth Quarter 2021 Revenue Increase of 25% Year-Over-Year
February 22, 2022
Insulet Promotes Inclusivity for People with Diabetes through Nintendo® Video Game Animal Crossing™: New Horizons
February 16, 2022
Insulet Announces Board Appointment of Elizabeth Weatherman and Retirement of David Lemoine
February 6, 2022
Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control
January 27, 2022
CORRECTING and REPLACING Insulet to Announce Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022
January 11, 2022